- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01743495
CAPABLE for Frail Dually Eligible Older Adults (CAPABLE500)
February 10, 2020 updated by: Johns Hopkins University
The Johns Hopkins School of Nursing offers this research study which aims to learn more about whether services that help with medications, muscle strengthening, pain management and changes to houses can help improve older adults' ability to, walk, and take care of themselves while saving costs by reducing hospitalizations and nursing home admissions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
- 65yrs or older
- Be able to stand (with or without assistance)
- Have some difficulty with getting dressed, or preparing food, bathing
- Receive a low monthly income
- Have no plans to move in the next year
- NOT be receiving home nursing or other therapy right now
Study Type
Interventional
Enrollment (Actual)
281
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Johns Hopkins University School of Nursing
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 65 or older
- Cognitively intact (≥ 10 on Brief Interview of Mental Status)
- Difficulty with ≥ 2 IADLS or ≥ 1 ADL
- ≤ 199% of Federal Poverty level
Exclusion Criteria:
Terminally ill
--Active cancer treatment
- Hospitalized > 3 times in last 3 years
- Receiving home nursing, Occupational Therapy or Physical Therapy
- Don't have phone or do plan to move in less than a year
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Functional Services
The program consists of up to 10 home-based functional services sessions over 4 months.
|
The program consists of up to 10 home-based functional services sessions over 4 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cost Effective
Time Frame: one year after intervention
|
Chart review to see change between cost of intervention to medicaid before and after CAPABALE
|
one year after intervention
|
Cost Effective
Time Frame: two years after intervention
|
Chart review to see change between cost of intervention to medicaid before and after CAPABALE
|
two years after intervention
|
Cost Effective
Time Frame: one year after intervention
|
Chart review to see change between cost of intervention to medicare before and after CAPABALE
|
one year after intervention
|
Cost Effective
Time Frame: two years after intervention
|
Chart review to see change between cost of intervention to medicare before and after CAPABALE
|
two years after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of Life as assessed by the Activities of Daily Living (ADL) Questionnaire
Time Frame: four months post intervention
|
The ADL Questionnaire will be used to assess quality of life in participants.
The score ranges from 0 to 32, with 0 being no help required with activities of daily life and 32 representing that the participant is incapable of completing activities of daily life regardless of difficulty without assistance.
|
four months post intervention
|
Quality of Life as assessed by the ADL Questionnaire
Time Frame: eight months post intervention
|
The ADL Questionnaire will be used to assess quality of life in participants.
The score ranges from 0 to 32, with 0 being no help required with activities of daily life and 32 representing that the participant is incapable of completing activities of daily life regardless of difficulty without assistance.
|
eight months post intervention
|
Quality of Life as assessed by the ADL Questionnaire
Time Frame: twelve months post intervention
|
The ADL Questionnaire will be used to assess quality of life in participants.
The score ranges from 0 to 32, with 0 being no help required with activities of daily life and 32 representing that the participant is incapable of completing activities of daily life regardless of difficulty without assistance.
|
twelve months post intervention
|
Quality of Life as assessed by the Instrumental Activities of Daily Living (IADL) Questionnaire
Time Frame: four months post intervention
|
The IADL Questionnaire will be used to assess quality of life in participants.
The score ranges from 0 to 32, with 0 being no help required with activities of daily life and 32 representing that the participant is incapable of completing instrumental activities of daily life regardless of difficulty without assistance.
|
four months post intervention
|
Quality of Life as assessed by the IADL Questionnaire
Time Frame: eight months post intervention
|
The IADL Questionnaire will be used to assess quality of life in participants.
The score ranges from 0 to 32, with 0 being no help required with activities of daily life and 32 representing that the participant is incapable of completing instrumental activities of daily life regardless of difficulty without assistance.
|
eight months post intervention
|
Quality of Life as assessed by the IADL Questionnaire
Time Frame: twelve months post intervention
|
The IADL Questionnaire will be used to assess quality of life in participants.
The score ranges from 0 to 32, with 0 being no help required with activities of daily life and 32 representing that the participant is incapable of completing instrumental activities of daily life regardless of difficulty without assistance.
|
twelve months post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sarah Szanton, Johns Hopkins University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Waldersen BW, Wolff JL, Roberts L, Bridges AE, Gitlin LN, Szanton SL. Functional Goals and Predictors of Their Attainment in Low-Income Community-Dwelling Older Adults. Arch Phys Med Rehabil. 2017 May;98(5):896-903. doi: 10.1016/j.apmr.2016.11.017. Epub 2016 Dec 19.
- Szanton SL, Alfonso YN, Leff B, Guralnik J, Wolff JL, Stockwell I, Gitlin LN, Bishai D. Medicaid Cost Savings of a Preventive Home Visit Program for Disabled Older Adults. J Am Geriatr Soc. 2018 Mar;66(3):614-620. doi: 10.1111/jgs.15143. Epub 2017 Nov 22.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2012
Primary Completion (Actual)
August 31, 2018
Study Completion (Actual)
August 31, 2019
Study Registration Dates
First Submitted
October 15, 2012
First Submitted That Met QC Criteria
December 4, 2012
First Posted (Estimate)
December 6, 2012
Study Record Updates
Last Update Posted (Actual)
February 12, 2020
Last Update Submitted That Met QC Criteria
February 10, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NA_00076471
- 1C1CMS330970-01-00 (Other Identifier: Centers for Medicare and Medicaid Services)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscle Weakness
-
St. Luke's-Roosevelt Hospital CenterCompletedFall Risk | Quadriceps Muscle Weakness | Adductor Muscle WeaknessUnited States
-
University of Central ArkansasCompletedPelvic Floor Muscle WeaknessUnited States
-
Association Pro-arteActive, not recruitingWeakness, Muscle | AmyotrophiaFrance
-
Ludwig Boltzmann Institute of Electrical Stimulation...Medical University of Vienna; European Union; Comenius University; Ministry of...CompletedMuscle Weakness Condition | Therapy EffectAustria, Slovakia
-
Rutgers, The State University of New JerseyRecruitingPhysical Disability | Muscle Atrophy or Weakness | Muscle Loss | Physical Inactivity | Delirium in Old Age | Hospital Acquired Condition | Weakness, MuscleUnited States
-
University of MilanCompleted
-
University of Central FloridaCompletedMuscle Weakness | Muscle Atrophy | Muscle Loss | Weakness, Muscle | Injury, KneeUnited States
-
University of Texas Southwestern Medical CenterTerminatedMuscle Cramp | Statin Adverse Reaction | Weakness, Muscle | AcheUnited States
-
Riphah International UniversityCompletedMuscle Weakness ConditionPakistan
-
Damanhour UniversityCompletedNeuromuscular Electrical Stimulation | ICU Acquired Muscle WeaknessEgypt